Please assess the completion status of the following clinical trial:

Trial Title: MOVIPREP® Versus PICOLAX® Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* written informed consent obtained prior to inclusion~* male or female, aged 18 to 80 years, inclusive, scheduled to undergo a complete colonoscopy~* willing, able and competent to complete the entire procedure and to comply with study instructions~* females of childbearing potential must employ an adequate method of contraception~* if an adequate method of contraception is not being used, the patient will be post hysterectomy, post bilateral oophorectomy, post menopause or have any other condition which precludes pregnancy~* females of childbearing potential must undergo a pregnancy test~Exclusion Criteria:~* ileus~* gastro-intestinal obstruction or perforation~* toxic megacolon, toxic colitis~* congestive heart failure (New York Heart Association \[NYHA\] III + IV)~* acute life-threatening cardiovascular disease~* acute surgical abdominal conditions~* untreated or uncontrolled arterial hypertension~* known clinically significant reduced renal function with creatinine \> 170 µmol/L~* known clinically significant reduced liver function

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): MOVIPREP
- 2 (Type: ACTIVE_COMPARATOR): Picolax

Based on this trial design, predict the completion outcome and termination type (if applicable).